Inflation-hit Pakistan on Friday approved a rise of up to 20% in retail prices of general medicines and 14% for essential ones, prompting immediate criticism from drug manufacturers who said the increases were too small.
https://www.pharmalive.com/wp-content/uploads/2023/04/ReutersPakistan4-28-2023.jpg8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-04-28 08:30:052023-04-28 10:54:41Pakistan hikes drug prices by 20%, manufacturers want more
